Cargando…

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database

INTRODUCTION: Although hospitals are key health service providers, their financial ties to drug companies are little understood. We examine non-research pharmaceutical industry payments to English National Health Service (NHS) trusts—hospital groupings providing secondary and tertiary care. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozieranski, Piotr, Saghy, Eszter, Mulinari, Shai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619808/ https://www.ncbi.nlm.nih.gov/pubmed/37910526 http://dx.doi.org/10.1371/journal.pone.0290022

Ejemplares similares

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Drug company payments to General Practices in England: Cross-sectional and social network analysis
por: Saghy, Eszter, et al.
Publicado: (2021)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022)

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
por: Fabbri, Alice, et al.
Publicado: (2018)

Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: a European policy review
por: Ozieranski, Piotr, et al.
Publicado: (2021)

Exposing drug industry funding of UK patient organisations
por: Ozieranski, Piotr, et al.
Publicado: (2019)

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
por: Kanter, Genevieve P., et al.
Publicado: (2019)

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
por: Rickard, Emily, et al.
Publicado: (2023)

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
por: Mulinari, Shai, et al.
Publicado: (2020)

Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe
por: Ozieranski, Piotr, et al.
Publicado: (2022)

Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2013)

Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment
por: Rhee, Taeho Greg, et al.
Publicado: (2020)

Contemporary Analysis of Inconsistencies Between Physician-reported Disclosures at the AAOS Annual Meeting and Industry-reported Financial Disclosures in the Open Payments Database
por: Bovonratwet, Patawut, et al.
Publicado: (2022)

The use of locum doctors in the NHS – results of a national survey of NHS Trusts in England
por: Stringer, Gemma, et al.
Publicado: (2023)

A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups
por: Rickard, Emily, et al.
Publicado: (2021)

Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
por: Stoll, Marlene, et al.
Publicado: (2020)

Facial plating industry payments: An analysis of the open payments database
por: Lorenz, F. Jeffrey, et al.
Publicado: (2023)

Low Vision Services Provision throughout NHS Trusts in the UK
por: Codina, Charlotte Joy, et al.
Publicado: (2023)

Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
por: Stoll, Marlene, et al.
Publicado: (2022)

Perspectives of clinical microbiologists on antimicrobial stewardship programmes within NHS trusts in England
por: Bailey, Chantelle, et al.
Publicado: (2015)

Are inspectors’ assessments reliable? Ratings of NHS acute hospital trust services in England
por: Boyd, Alan, et al.
Publicado: (2016)

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
por: Robertson, Jane, et al.
Publicado: (2009)

Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study
por: Norris, Susan L, et al.
Publicado: (2012)

Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2015)

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012
por: Vilhelmsson, Andreas, et al.
Publicado: (2016)

Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
por: Saito, Hiroaki, et al.
Publicado: (2019)

Female dermatology journal editors accepting pharmaceutical payments: An analysis of the Open Payments database, 2013 to 2018
por: Haque, Waqas, et al.
Publicado: (2021)

Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
por: Vilhelmsson, Andreas, et al.
Publicado: (2018)

A cross-sectional study of all clinicians’ conflict of interest disclosures to NHS hospital employers in England 2015-2016
por: Feldman, Harriet Ruth, et al.
Publicado: (2018)

Review of Industry Payments to General Orthopaedic Surgeons Reported by the Open Payments Database: 2014 to 2019
por: Braithwaite, Johann, et al.
Publicado: (2021)

Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
por: Karanges, Emily Aspasia, et al.
Publicado: (2021)

Use of locum doctors in NHS trusts in England: analysis of routinely collected workforce data 2019–2021
por: Grigoroglou, Christos, et al.
Publicado: (2023)

Public perceptions of physician-pharmaceutical industry relationships and trust in physicians
por: Saito, Sayaka, et al.
Publicado: (2023)

Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment
por: Kanter, Genevieve P, et al.
Publicado: (2019)

Policies for Tobacco and E-Cigarette Use: A Survey of All Higher Education Institutions and NHS Trusts in England
por: Blackwell, Anna K M, et al.
Publicado: (2019)

What are the financial implications of an open right hemicolectomy to hospital trusts within NHS England? A cost analysis
por: Daniels, Ian, et al.
Publicado: (2021)

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cj9t31lpga4g95vnu7i4bkq6j6